Structure–activity relationships of 2-arylamido-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists and their analgesic action
Authors:
- 1 December 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (24) , 7314-7321
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Selective cannabinoid receptor 2 modulators: a patent review 2009 – presentExpert Opinion on Therapeutic Patents, 2012
- A Survey of Recent Patents on CB2 Agonists in the Management of PainRecent Patents on CNS Drug Discovery, 2012
- Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptorsProceedings of the National Academy of Sciences, 2012
- Endocannabinoid-mediated synaptic plasticity and addiction-related behaviorNeuropharmacology, 2011
- Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunitiesBiochemical Pharmacology, 2010
- Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomasGlia, 2010
- Functional CB2 type cannabinoid receptors at CNS synapsesNeuropharmacology, 2009
- The role of CB1 receptors in psychostimulant addictionAddiction Biology, 2008
- Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in BrainAnnals of the New York Academy of Sciences, 2006
- [General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNSCurrent Medicinal Chemistry, 2003